Business Context and Reporting Period
Power & Digital Infrastructure Acquisition Corp. (now associated with Core Scientific’s predecessor transaction) filed this Form 8-K regarding its initial public offering and related agreements. The report date was February 9, 2021; the IPO and related transactions were consummated on February 12, 2021.
The company was a special purpose acquisition company formed to pursue an initial business combination. The filing does not describe operating revenue or an operating business.
Key Financial and Capitalization Metrics
- IPO: 34.5 million units sold at $10.00 per unit, generating gross proceeds of $345.0 million. The amount included the underwriters’ full option to purchase 4.5 million additional units.
- Unit composition: Each unit consisted of one Class A common share and one-fourth of a public warrant.
- Public warrants: Each whole warrant is exercisable for one Class A common share at $11.50 per share.
- Private placement: 6,266,667 private placement warrants were sold at $1.50 each, generating total proceeds of $9,400,000.50. Of these, the Sponsor purchased 5,013,333 warrants.
- Trust account: Net IPO proceeds and certain private-placement proceeds were to be held in a trust account under the Investment Management Trust Agreement.
- Administrative costs: The Sponsor agreed to provide office space and administrative services for $20,000 per month until the initial business combination or liquidation.
- Profit, cash flow, margins, debt, and liquidity: The filing text does not provide clear values for net income, cash flow, operating margins, debt, or post-closing liquidity beyond the IPO and private-placement proceeds.
Material Changes and Agreements
- The SEC declared the company’s Form S-1 registration statement effective on February 9, 2021, followed by the IPO on February 12, 2021.
- The company entered into underwriting, warrant, trust-account, registration-rights, letter, and administrative-services agreements.
- The company adopted an Amended and Restated Certificate of Incorporation on February 12, 2021.
- The Sponsor and officers and directors agreed to vote their shares in favor of the initial business combination and to facilitate liquidation if a business combination is not completed within 24 months.
- The Sponsor retained the right to nominate three individuals for election to the board after the initial business combination, subject to the applicable agreement.
Outlook, Risks, and Unusual Items
- The company had not yet completed an initial business combination and was dependent on identifying and consummating a suitable transaction.
- If no business combination is completed within 24 months, the company expects to liquidate, subject to the terms of its governing documents.
- Public and private warrants contain different redemption, exercise, transfer-restriction, and cashless-exercise features. Private warrants generally receive special treatment while held by the Sponsor, Anchor Investors, or permitted transferees.
- The filing does not provide management guidance, revenue outlook, earnings forecasts, or commentary regarding Core Scientific’s operating performance.
- The filing’s transaction timing should be verified because it is dated February 9, while several described transactions occurred on February 12, 2021.
Investor Verification Checklist
- Verify the final amount deposited into the trust account after underwriting discounts, offering expenses, and other transaction costs.
- Review the complete warrant agreement for redemption triggers, exercise terms, adjustment provisions, and potential dilution.
- Confirm the 24-month deadline and liquidation provisions in the Amended and Restated Certificate of Incorporation.
- Review the registration and stockholder rights agreement for Sponsor and Anchor Investor rights and transfer restrictions.
- Confirm that the filing provides no operating financial metrics, debt data, or business-combination target information beyond the capital-raising transactions.